Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06598397 · ClinicalTrials.gov registry record · Phase 4
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
A Phase 4 study of Smoking Cessation and Human Immunodeficiency Virus (HIV), sponsored by New York University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT06598397 is a Phase 4 study of Smoking Cessation and Human Immunodeficiency Virus (HIV) that is actively recruiting participants, run by New York University. The registered enrollment target is 500 participants, roughly in line with the 472-participant average among 188 other Smoking Cessation trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06598397, a Phase 4 study of Smoking Cessation and Human Immunodeficiency Virus (HIV), is actively recruiting participants, sponsored by New York University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study's long-term goal is to improve clinical outcomes among smokers living with HIV (SLWH) by providing smoking cessation interventions in HIV clinical care that will increase the chances of quitting smoking, limits costs and burden on staff and reach many smokers living with HIV.
Conditions Studied
Interventions
- BEHAVIORAL Motivational Interviewing (MI) Counseling
- BEHAVIORAL Peer Mentoring
- BEHAVIORAL Skills-based Text Messaging
- DRUG Combination NRT
Study Locations (1)
New York
- New York University School of Global Public Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-10-18 |
| Est. Completion | 2028-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06598397
The ClinicalTrials.gov registry entry for NCT06598397 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 472-participant average among 188 other Smoking Cessation trials with a reported enrollment target. The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 4 interventions - of which Motivational Interviewing (MI) Counseling is the first listed.
NCT06598397 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06598397 about?
NCT06598397 is a clinical study titled "Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care". This study's long-term goal is to improve clinical outcomes among smokers living with HIV (SLWH) by providing smoking cessation interventions in HIV clinical care that will increase the chances of quitting smoking, limits costs and burden on staff and reach many smokers living with HIV.
What is the current status of trial NCT06598397?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 500 participants. The study started on 2024-10-18. Estimated completion is 2028-06-30.
What conditions does trial NCT06598397 study?
This clinical trial studies the following conditions: Smoking Cessation, Human Immunodeficiency Virus (HIV).
What interventions are being tested in trial NCT06598397?
The interventions under investigation include: Motivational Interviewing (MI) Counseling (BEHAVIORAL), Peer Mentoring (BEHAVIORAL), Skills-based Text Messaging (BEHAVIORAL), Combination NRT (DRUG).
Who is sponsoring clinical trial NCT06598397?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06598397 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
The Options 2 Study
RECRUITING · Phase 4
-
Smoking Cessation Program in the Construction Sector
RECRUITING · Phase 4
-
The Avenues Study: Dual Use Cessation
RECRUITING · Phase 4
-
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
ACTIVE NOT RECRUITING · Phase 4
-
Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.